reboxetine mesilate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
EDRONAX reboxetine 4mg (as mesilate) tablet blister pack
AUST R: 79745
Active ingredients:
reboxetine mesilate

Dosage form:
Tablet, uncoated

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

From
05 May 2025
to
25 Aug 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Sponsor is working to expedite the next shipment.